ALLMedicine™ Acute Liver Failure Center
Research & Reviews 1,844 results
ASAIO Journal (American Society for Artificial Internal O... Mehta S, Fried J et. al.
Feb 3rd, 2023 - We applied the Society for Cardiovascular Angiography and Interventions (SCAI) schema to cardiogenic shock (CS) patients treated with venoarterial extracorporeal membrane oxygenation (VA-ECMO) to assess performance in this high acuity group of pat...
Clinical Transplantation; Cloonan DJ, Cloonan MR et. al.
Feb 2nd, 2023 - Effects of kidney injury at the time of liver transplantation (LT) for acute liver failure (ALF) remain poorly described. We hypothesized that patients with ALF and kidney injury (KI) who undergo LT have persistent post-transplant KI, inferior sur...
The American Journal of Case Reports; Yoon U, Lai M et. al.
Feb 1st, 2023 - BACKGROUND Fulminant hepatic failure (FHF) is commonly associated with elevated prothrombin time (PT) and international normalized ratio (INR). There is a commensurate decline in pro- and anti-hemostatic factors, and hemostatic function is rebalan...
Clinical and Translational Gastroenterology; Rakela JL, Karvellas CJ et. al.
Jan 31st, 2023 - Acute Liver Failure: Biomarkers Evaluated by the Acute Liver Failure Study Group.|2023|Rakela JL,Karvellas CJ,Koch DG,Vegunta S,Lee WM,|
Pediatric Nephrology (Berlin, Germany); Collignon C, de Marcellus C et. al.
Jan 27th, 2023 - Continuous venovenous hemodiafiltration (CVVHDF) is one of the treatments of critically ill children presenting severe acute liver failure. This affliction might be induced by HSV infection requiring a treatment by acyclovir. Continuous kidney rep...
Guidelines 1 results
Clinical Nutrition (Edinburgh, Scotland); Bischoff SC, Bernal W et. al.
Nov 21st, 2020 - The Practical guideline is based on the current scientific ESPEN guideline on Clinical Nutrition in Liver Disease. It has been shortened and transformed into flow charts for easier use in clinical practice. The guideline is dedicated to all profes...
Drugs 46 results see all →
Clinicaltrials.gov 87 results
Jan 26th, 2023 - Though HAV is mainly transmitted through the fecal-oral route, infection by sexual intercourse and blood transfusion is also possible. Injection drug users (IDUs) and men who have sex with men (MSM) have a higher risk of acquiring HAV due to their...
Jan 26th, 2023 - Acute pancreatitis in emergency surgery ranks third in frequency of its manifestation, second only to acute appendicitis and cholecystitis. The incidence of acute pancreatitis is growing from year to year and is more than 38 patients per 10,000 po...
Dec 6th, 2022 - Pediatric Acute Liver Failure (PALF) is a rare, devastating condition that affects an estimated 250 children per year in North America, causing death in approximately 15% and the need for liver transplantation in an additional 20-30%. In the major...
Nov 14th, 2022 - This study aimed to evaluate citrate PKs, metabolic complications, and clinical outcomes among critically ill acute liver failure (ALF) and acute on top chronic liver failure (ACLF) patients receiving CRRT.
Oct 28th, 2022 - To investigate the safety of Stemchymal® via intravenous (IV) infusion in acute liver failure (ALF) and acute on chronic liver failure (ACLF) patients.
News 139 results
Jan 17th, 2023 - Being socially isolated was associated with a 28% higher risk of incident dementia over 9 years, data from the National Health and Aging Trends Study showed. (Journal of the American Geriatrics Society) Six minutes of high-intensity exercise boost...
Sep 2nd, 2022 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Patients with COVID-19 who experience gastrointestinal symptoms have overall worse in-hospital complications but less cardiomyopathy and mortality...
Aug 26th, 2022 - Patients with COVID-19 who experience gastrointestinal symptoms have overall worse in-hospital complications but less cardiomyopathy and mortality, according to a new study. About 20% of COVID-19 patients experience gastrointestinal symptoms, such.
Aug 12th, 2022 - (Reuters) - Novartis AG on Thursday reported two patient fatalities due to acute liver failure following treatment with Zolgensma gene therapy used to treat spinal muscular atrophy. The company has notified health authorities in markets where the ...
Aug 12th, 2022 - Two children taking the gene therapy drug onasemnogene abeparvovec (Zolgensma, Novartis) for spinal muscular atrophy (SMA) have died from acute liver failure, according to a statement issued by the drug's manufacturer. The patients were 4 months a...